Valar Labs
Palo Alto, US · Founded 2021 · Delaware corporation · 5 known investors
Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.
Founders & leadership
Valar Labs was founded in 2021 by Anirudh Joshi, Viswesh Krishna, and Damir Vrabac.
AJ
Anirudh JoshiinCo-founder & CEOAnirudh Joshi is a researcher focused on AI in medicine and the co-founder and CEO of Valar Labs, which builds AI-powered pathology analysis tools to guide cancer treatment decisions for physicians and oncology practices.30 Under 30 2025
VK
Viswesh KrishnaCo-founder & CTO30 Under 30 2025
DV
Investors · 5
Funding
SEC filings, press & company announcements$26.1M disclosed across 2 rounds · 2021–2024
- $22MSeries AMay 2024 · 2 sourcesSource ↗
▶$4.1MraisedApr 2022 · 19 investors · OtherRule 506(b)
▶$4.1MraisedApr 2022 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anirudh Rajiv JoshiExecutive Officer, Director
- Damir VrabacExecutive Officer, Director
- Viswesh KrishnaExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapValo11 shared keywordsValo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields. It positions itself as a company focused on reshaping how new drugs are discovered.
Valora Therapeutics7 shared keywordsValora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Rupa Health5 shared keywordsA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
Valotx5 shared keywordsValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.
IQVIA5 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Volastra5 shared keywordsVolastra Therapeutics is a drug discovery and development company working on novel cancer therapies. Its team spans drug discovery, clinical development, and business strategy to bring new oncology treatments to patients.
Companies competing with Valar Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Valar Labs do?
- Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.
- Who founded Valar Labs?
- Valar Labs was founded by Anirudh Joshi, Viswesh Krishna, Damir Vrabac in 2021.
- Who are Valar Labs's investors?
- Valar Labs's investors include DCVC (Data Collective), Andreessen Horowitz, Martin Ventures, REMUS Capital, Pear VC.
- How much funding has Valar Labs raised?
- Valar Labs has disclosed $26.1M raised across 2 rounds.
- Where is Valar Labs headquartered?
- Valar Labs is headquartered in Palo Alto, US.